DIRECT (DLBCL Interim Response Evaluation for Customised Therapy)

Trial description
This study will establish whether molecular information from both the diagnostic biopsy and from ctDNA can be integrated with PET-CT results to provide an accurate, early assessment of response to treatment.
Contact name
Dr Daniel Hodson
Trial start date
Tuesday, January 1, 2019
Trial end date
Friday, January 1, 2021
Trial tumour type
Haematological
Show on Radiotherapy
No